UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Maternal treatment with oral intestinal alkaline phosphatase mitigates high fat diet-induced cognitive disorders in offspring mice

Behavioural brain research, 2020-08, Vol.392, p.112701-112701, Article 112701

2020

Volltextzugriff (PDF)

Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model

Blood, 2009-11, Vol.114 (20), p.4562-4565

2009

Volltextzugriff (PDF)

Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality

Blood, 2009-03, Vol.113 (12), p.2859-2866

2009

Volltextzugriff (PDF)

Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV

Current topics in medicinal chemistry, 2016-01, Vol.16 (10), p.1118

2016

Volltextzugriff (PDF)

Emerging role of regulatory T cells in gene transfer

Current gene therapy, 2007-10, Vol.7 (5), p.381

2007

Volltextzugriff (PDF)

1140 – Syn-007, an Oral Beta-Lactamase Prevents Gut Microbime Dysbiosis Caused by Oral Amoxicillin and Oral Amoxicillin/Clavulanate Without Affecting Amoxicillin Systemic Absorption in Dogs

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-241-S-242

2019

Volltextzugriff (PDF)

Sa1839 - Orally Delivered Beta-Lactamase Prevents Gut Microbiome Dysbiosis Caused by IV and Oral Antibiotics and Mitigates Propagation of Antibiotic Resistance in Porcine and Canine Models

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-415-S-415

2018

Volltextzugriff (PDF)

Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s)

Haematologica (Roma), 2004-12, Vol.89 (12), p.1504

2004

Volltextzugriff (PDF)

332g - An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1305-S1306

2017

Volltextzugriff (PDF)

Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency

Thrombosis and haemostasis, 2003-12, Vol.90 (6), p.1220

2003

Volltextzugriff (PDF)

An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1305-S1306

2017

Volltextzugriff (PDF)

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S307-S307

2019

Volltextzugriff (PDF)

A Crucial Role for Caspase 1 in Thrombo-Inflammatory Microparticle Release

Blood, 2014-12, Vol.124 (21), p.2806-2806

2014

Volltextzugriff (PDF)

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S226-S226

2018

Volltextzugriff (PDF)

Inflammation, Obesity, and Thrombosis

Blood, 2012-11, Vol.120 (21), p.SCI-45-SCI-45

2012

Volltextzugriff (PDF)

SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S231-S232

2017

Volltextzugriff (PDF)

Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S232-S233

2017

Volltextzugriff (PDF)

Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin efflux

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.981

2012

Volltextzugriff (PDF)

Thrombosis and Inflammation Are Coupled by a Common Thioredoxin Reductase Pathway Downstream of the P2×7 Receptor

Blood, 2012-11, Vol.120 (21), p.2218-2218

2012

Volltextzugriff (PDF)

Protease-Activated Receptor 4 (PAR4) Plays a Critical Role in Fetal Loss and Peripheral Thrombosis in a Mouse Model of Thrombophilia

Blood, 2011-11, Vol.118 (21), p.373-373

2011

Volltextzugriff (PDF)

Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation

Nature medicine, 2011-10, Vol.17 (11), p.1490-1497

2011

Volltextzugriff (PDF)

P2×7 Signaling Triggers Tissue Factor Activation and Protein Disulfide Isomerase-Dependent Release of TF+ Microparticles In Thrombosis

Blood, 2010-11, Vol.116 (21), p.344-344

2010

Volltextzugriff (PDF)

Novel Infrared Fluorescence Methodology Defines An Essential Role for Endothelial Protein C Receptor (EPCR) for Protection Against Vascular Leakage In Inflammation

Blood, 2010-11, Vol.116 (21), p.653-653

2010

Volltextzugriff (PDF)

Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models

Blood, 2006-11, Vol.108 (11), p.1471-1471

2006

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaCellular Signal Transduction

ThemaInflammation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Animals
(7)
Hematology
(5)
Humans
(5)
Biological And Medical Sciences
(3)
Female
(3)
Hematologic And Hematopoietic Diseases
(3)
Medical Sciences
(3)
Mice
(3)
Mice, Inbred C57bl
(3)
Abstracts
(2)
Amino Acid Sequence
(2)
Anticoagulants
(2)
Atherosclerosis
(2)
Capillary Permeability - Physiology
(2)
Cardiovascular System & Cardiology
(2)
Disease Models, Animal
(2)
Factor Vii - Genetics
(2)
Factor Vii Deficiency - Genetics
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maternal treatment with oral intestinal alkaline phosphatase mitigates high fat diet-induced cognitive disorders in offspring mice

Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model

Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality

Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV

Emerging role of regulatory T cells in gene transfer

1140 – Syn-007, an Oral Beta-Lactamase Prevents Gut Microbime Dysbiosis Caused by Oral Amoxicillin and Oral Amoxicillin/Clavulanate Without Affecting Amoxicillin Systemic Absorption in Dogs

Sa1839 - Orally Delivered Beta-Lactamase Prevents Gut Microbiome Dysbiosis Caused by IV and Oral Antibiotics and Mitigates Propagation of Antibiotic Resistance in Porcine and Canine Models

Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s)

332g - An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency

An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

A Crucial Role for Caspase 1 in Thrombo-Inflammatory Microparticle Release

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis

Inflammation, Obesity, and Thrombosis

SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens

Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models

Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin efflux

Thrombosis and Inflammation Are Coupled by a Common Thioredoxin Reductase Pathway Downstream of the P2×7 Receptor

Protease-Activated Receptor 4 (PAR4) Plays a Critical Role in Fetal Loss and Peripheral Thrombosis in a Mouse Model of Thrombophilia

Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation

P2×7 Signaling Triggers Tissue Factor Activation and Protein Disulfide Isomerase-Dependent Release of TF+ Microparticles In Thrombosis

Novel Infrared Fluorescence Methodology Defines An Essential Role for Endothelial Protein C Receptor (EPCR) for Protection Against Vascular Leakage In Inflammation

Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models

Aktive Filter

Suchergebnisse filtern